B7 Family Member Zb7H6 And Related Compositions And Methods - EP2197489

The patent EP2197489 was granted to Zymogenetics on Apr 1, 2020. The application was originally filed on Oct 6, 2008 under application number EP08835652A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2197489

ZYMOGENETICS
Application Number
EP08835652A
Filing Date
Oct 6, 2008
Status
Patent Maintained As Amended
Feb 28, 2020
Grant Date
Apr 1, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEFeb 9, 2018CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (99) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO1996US10287
DESCRIPTIONEP0036776
DESCRIPTIONEP0127839
DESCRIPTIONEP0154316
DESCRIPTIONEP0155476
DESCRIPTIONEP0244234
DESCRIPTIONJPH04244018
DESCRIPTIONUS2003083263
DESCRIPTIONUS2007254339
DESCRIPTIONUS4331647
DESCRIPTIONUS4399216
DESCRIPTIONUS4486414
DESCRIPTIONUS4551433
DESCRIPTIONUS4560655
DESCRIPTIONUS4657866
DESCRIPTIONUS4745051
DESCRIPTIONUS4767704
DESCRIPTIONUS4816444
DESCRIPTIONUS4837148
DESCRIPTIONUS4879278
DESCRIPTIONUS4880935
DESCRIPTIONUS4883662
DESCRIPTIONUS4927762
DESCRIPTIONUS4929555
DESCRIPTIONUS4946778
DESCRIPTIONUS4978744
DESCRIPTIONUS4986988
DESCRIPTIONUS5010175
DESCRIPTIONUS5011912
DESCRIPTIONUS5037743
DESCRIPTIONUS5076973
DESCRIPTIONUS5082833
DESCRIPTIONUS5122368
DESCRIPTIONUS5138036
DESCRIPTIONUS5143830
DESCRIPTIONUS5208036
DESCRIPTIONUS5208146
DESCRIPTIONUS5223409
DESCRIPTIONUS5264618
DESCRIPTIONUS5279833
DESCRIPTIONUS5283185
DESCRIPTIONUS5288514
DESCRIPTIONUS5382657
DESCRIPTIONUS5399346
DESCRIPTIONUS5410024
DESCRIPTIONUS5504191
DESCRIPTIONUS5506337
DESCRIPTIONUS5519134
DESCRIPTIONUS5521284
DESCRIPTIONUS5525735
DESCRIPTIONUS5530097
DESCRIPTIONUS5539083
DESCRIPTIONUS5549974
DESCRIPTIONUS5554725
DESCRIPTIONUS5556623
DESCRIPTIONUS5569588
DESCRIPTIONUS5593853
DESCRIPTIONUS5599902
DESCRIPTIONUS5622929
DESCRIPTIONUS5635483
DESCRIPTIONUS5637677
DESCRIPTIONUS5641655
DESCRIPTIONUS5643573
DESCRIPTIONUS5654173
DESCRIPTIONUS5663149
DESCRIPTIONUS5665358
DESCRIPTIONUS5665860
DESCRIPTIONUS5693762
DESCRIPTIONUS5723125
DESCRIPTIONUS5738846
DESCRIPTIONUS5750375
DESCRIPTIONUS5780588
DESCRIPTIONUS5824805
DESCRIPTIONUS6018026
DESCRIPTIONUS6034065
DESCRIPTIONUS6130237
DESCRIPTIONUS6214345
DESCRIPTIONUS6239104
DESCRIPTIONUS6323315
DESCRIPTIONUS6884869
DESCRIPTIONUS8060852
DESCRIPTIONUSRE30985E
DESCRIPTIONWO02088172
DESCRIPTIONWO2004010957
DESCRIPTIONWO8700195
DESCRIPTIONWO8912624
DESCRIPTIONWO9003430
DESCRIPTIONWO9100357
DESCRIPTIONWO9111465
DESCRIPTIONWO9119735
DESCRIPTIONWO9200091
DESCRIPTIONWO9206204
DESCRIPTIONWO9320242
DESCRIPTIONWO9412629
DESCRIPTIONWO9505853
DESCRIPTIONWO9720078
INTERNATIONAL-SEARCH-REPORTWO0151514
INTERNATIONAL-SEARCH-REPORTWO2006124668
OPPOSITIONWO0151514

Non-Patent Literature (NPL) Citations (336) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- 1TO ET AL., J. BACTERIOL., (1983), vol. 153, page 163
DESCRIPTION- ABBAS ET AL., NAT. MED., (1999), vol. 5, pages 1345 - 6
DESCRIPTION- ADANG ET AL., PLANT MOLEC. BIOL., (1993), vol. 21, page 1131
DESCRIPTION- AHMAD; ALVAREZ, J. LEUKOC., (2004), vol. 76, pages 743 - 759
DESCRIPTION- ALLCN ET AL., BIOCHIM. BIOPHYS. ACTA, (1993), vol. 1150, page 9
DESCRIPTION- ALLEN ET AL., BIOCHIM. BIOPHYS. ACTA, (1991), vol. 1068, page 133
DESCRIPTION- ALLEN ET AL., BIOCHIM. BIOPHYS. ACTA, (1993), vol. 1150, page 9
DESCRIPTION- ALTSCHUL ET AL., BULL. MATH. BIO., (1986), vol. 48, page 603
DESCRIPTION- ANDERSON ET AL., CANCER RES., (1990), vol. 50, page 1853
DESCRIPTION- ANDERSON ET AL., INFECT. IMMUN., (1981), vol. 31, page 1099
DESCRIPTION- ANSCLL ET AL., LEUKEMIA, (2004), vol. 18, pages 616 - 23
DESCRIPTION- ANSELL, BLOOD, (2002), vol. 99, pages 67 - 74
DESCRIPTION- ATKINS ET AL., J CLIN. ONCOL., (1999), vol. 17, pages 2105 - 16
DESCRIPTION- "Avidin-Biotin Technology", Methods In Enzymology, ACADEMIC PRESS, (1990), vol. 184
DESCRIPTION- AVIV; LEDER, PROC. NUL'L ACAD. SCI. USA, (1972), vol. 69, page 1408
DESCRIPTION- AZUMA ET AL., NATURE, (1993), vol. 366, page 76
DESCRIPTION- BAKER, LARYNGOSCOPE, (1985), vol. 95, pages 43 - 56
DESCRIPTION- BAKKER-WOUDENBERG ET AL., EUR..1. CLIN. MICROHIOL. INFECT. DIS., (1993), vol. 12, no. 1, page 61
DESCRIPTION- BALLANCE ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1983), vol. 112, pages 284 - 289
DESCRIPTION- BAMBOT ET AL., PCR METHODS AND APPLICATIONS, (1993), vol. 2, page 266
DESCRIPTION- BARAO; MURPHY, BB&MT, (2003), vol. 9, pages 727 - 741
DESCRIPTION- BARNES; SATO, ANAL. BIOCHEM., (1980), vol. 102, page 255
DESCRIPTION- BARTUS ET AL., SCIENCE, (1998), vol. 281, page 1161
DESCRIPTION- BASS ET AL., PROC. NAT'L ACAD. SCI. USA, (1991), vol. 88, page 4498
DESCRIPTION- BAUM, C&EN, (19930118), page 33
DESCRIPTION- BAYER; RAPP, CHEM. PEPT. PROT., (1986), vol. 3, page 3
DESCRIPTION- BEACH; NURSE, NATURE, (1981), vol. 300, page 706
DESCRIPTION- BELLO ET AL., CLIN. CANCER RES., (2002), vol. 8, pages 3539 - 48
DESCRIPTION- BETT ET AL., J. VIROL., (1993), vol. 67, page 5911
DESCRIPTION- Biochcmica, ROCHE MOLECULAR BIOCHEMICALS, (1999), pages 34 - 37
DESCRIPTION- BIRD ET AL., SCIENCE, (1988), vol. 242, page 423
DESCRIPTION- BONAVITA ET AL., INT. J. TISSUE REACT., (1993), vol. 15, pages 11 - 16
DESCRIPTION- BOSHART ET AL., CELL, (1985), vol. 41, page 521
DESCRIPTION- BOWIE; SAUER, PROC. NAT'L ACAD. SCI. USA, (1989), vol. 86, page 2152
DESCRIPTION- BOYE ET AL., ANNALS OFONCOL., (2003), vol. 14, pages 520 - 535
DESCRIPTION- BOYTON; ALTMANN, CLIN. EXP. IMMUNOL., (2007), vol. 149, pages 1 - 8
DESCRIPTION- BRAAKHUIS ET AL., CANCER RES., (1991), vol. 51, pages 211 - 4
DESCRIPTION- BREMER ET AL., PHARM. BIOTECHNOL., (1997), vol. 10, page 239
DESCRIPTION- BRITTEENDEN ET AL., CANCER, (1996), vol. 77, pages 1226 - 1243
DESCRIPTION- CAMPBELL ET AL., J. ORG. CHEM., (1994), vol. 59, page 658
DESCRIPTION- CAO ET AL., CLIN. CANCER RES., (1999), vol. 5, pages 1925 - 34
DESCRIPTION- CARBONCLL ET AL., GENE, (1988), vol. 73, page 409
DESCRIPTION- CARRENO ET AL., ANNU. REV. IMMUNOL., (2002), vol. 20, pages 29 - 53
DESCRIPTION- CARSON ET AL., EUR. J. IMMUNOL., (2001), vol. 31, pages 3016 - 25
DESCRIPTION- CARTER ET AL., PROC. NAT'1 ACAD. SCI. USA, (1992), vol. 89, page 4285
DESCRIPTION- CHAMBERS ET AL., ANN. REV. IMMUNOL., (2001), vol. 19, pages 565 - 594
DESCRIPTION- CHAMBERS ET AL., ANN. REV. IMMUNOL., (2001), vol. 19, pages 565 - 94
DESCRIPTION- CHANG ET AL., NATURE, (1978), vol. 275, page 615
DESCRIPTION- CHARI ET AL., CANCER RES., (1992), vol. 52, pages 127 - 131
DESCRIPTION- CHEN ET AL., J. AMER. CHEM. SOC., (1994), vol. 116, page 2661
DESCRIPTION- CHO ET AL., SCIENCE, (1993), vol. 261, page 1303
DESCRIPTION- CHUNG ET AL., PROC. NAT'L ACAD. SCI. USA, (1993), vol. 90, page 10145
DESCRIPTION- CHUNG ET AL., SCIENCE, (1993), vol. 259, page 806
DESCRIPTION- CLAASSEN ET AL., BIOCHIM. BIOPHYS. ACTA, (1984), vol. 802, page 428
DESCRIPTION- CLIMIE ET AL., PROC. NAT'L ACAD. SCI. USA, (1990), vol. 87, page 633
DESCRIPTION- COHEN ET AL., BIOCHIM. BIOPHYS. ACTA, (1991), vol. 1063, page 95
DESCRIPTION- "Constructing and Screening cDNA Libraries in Xgt 10 and ?gt11", HUYNH ET AL., DNA Cloning: A Practical Approach, IRL PRESS, (1985), vol. I, page 49
DESCRIPTION- CONTENT ET AL., "Expression and preliminary deletion analysis of the 42 kDa 2-5A synthetase induced by human interferon", BIOLOGICAL INTERFERON SYSTEMS, PROCEEDINGS OF ISIR-TNO MEETING ON INTERFERON SYSTEMS, (1987), pages 65 - 72
DESCRIPTION- COUMAILLEAU ET AL., J. BIOL. CHEM., (1995), vol. 270, page 29270
DESCRIPTION- COYLE ET AL., NUT. IMMUNOL., (2001), vol. 2, pages 203 - 9
DESCRIPTION- CREGG ET AL., MOL. CELL. BIOL., (1985), vol. 5, page 3376
DESCRIPTION- CUDOWICZ; BENNETT, J. EXP. MED., (1971), vol. 134, pages 83 - 102
DESCRIPTION- CUDOWICZ; BENNETT, J. EXP. MED., (1971), vol. 135, pages 1513 - 1528
DESCRIPTION- CUNNINGHAM; WCLLS, SCIENCE, (1989), vol. 244, page 1081
DESCRIPTION- Current Protocols in Immunology, JOHN WILEY & SONS, (1991), vol. 1, pages 2.5.1 - 2.6.7
DESCRIPTION- DAS ET AL., J. BACTERIOL., (1984), vol. 158, page 1165
DESCRIPTION- DAVIDOW ET AL., CURR. GENET., (1985), vol. 10, page 380
DESCRIPTION- DAWSON ET AL., SCIENCE, (1994), vol. 266, page 776
DESCRIPTION- DAWSON, METHODS ENZYMOL., (1997), vol. 287, page 34
DESCRIPTION- DC VOS ET AL., SCIENCE, (1992), vol. 255, page 306
DESCRIPTION- DEBOER ET AL., PROC. NATL. ACAD. SCI. USA, (1983), vol. 80, pages 21 - 25
DESCRIPTION- "Degradable Controlled Release Systems Useful for Protein Delivery", ROSKOS; MASKIEWICZ, Protein Delivery: Physical Systems, PLCNUM PRESS, (1997), pages 45 - 92
DESCRIPTION- DELGADO ET AL., CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, (1992), vol. 9, page 249
DESCRIPTION- "Delivery of Proteins from a Controlled Release Injectable Implant", YEWEY ET AL., Protein Delivery: Physical Systems, PLENUM PRESS, (1997), pages 93 - 117
DESCRIPTION- DE LOUVENCOURT ET AL., J. BACTERIOL., (1983), vol. 154, page 737
DESCRIPTION- DEMARS, EUR. ./. IMMUNOL., (1989), vol. 19, pages 447 - 451
DESCRIPTION- DERBYSHIRE ET AL., GENE, (1986), vol. 46, page 145
DESCRIPTION- DIEFENBACH; RAULET, IMMUNOL. REV., (2001), vol. 181, pages 170 - 184
DESCRIPTION- DIJKCMA ET AL., EMBO J., (1985), vol. 4, page 761
DESCRIPTION- DOWNS ET AL., GYNECOL. ONCOL., (2005), vol. 98, pages 203 - 10
DESCRIPTION- DUBENSKY ET AL., I VIROL., (1996), vol. 70, pages 508 - 519
DESCRIPTION- DUBOWCHIK; WALKER, PHARM. THERAPEUTICS, (1999), vol. 83, pages 67 - 123
DESCRIPTION- DUKE; COHEN ET AL., Current Protocols In Immunology, (1992), pages 3.17.1 - 3.17.16
DESCRIPTION- DUNCAN; SPREAFICO, CLIN. PHARMACOKINET., (1994), vol. 27, page 290
DESCRIPTION- EDELMAN ET AL., Methods in Enzymology, ACADEMIC PRESS, (1967), vol. 1, page 422
DESCRIPTION- EGEN ET AL., NATURE IMMUNOL, (2002), vol. 3, pages 611 - 618
DESCRIPTION- EHRKE ET AL., CANCER IMMUNOL. IMMUNOTHER., (1996), vol. 42, pages 221 - 30
DESCRIPTION- ELLMAN ET AL., METHODS ENZYMOL., (1991), vol. 202, page 301
DESCRIPTION- EMINI ET AL., J. VIROLOGY, (1985), vol. 55, page 836
DESCRIPTION- "Engineering Therapeutic Antibodies", KELLEY ET AL., Protein Engineering: Principles and Practice, JOHN WILEY & SONS, INC., (1996), pages 399 - 434
DESCRIPTION- EVANS ET AL., J. MED. CHEM., (1987), vol. 30, page 1229
DESCRIPTION- "Expression of Cloned Genes in Yeast", ROMANOS ET AL., DNA Cloning 2: A Practical Approach, OXFORD UNIVERSITY PRESS, (1995), pages 123 - 167
DESCRIPTION- "Expression of Engineered Proteins in Mammalian Cell Culture", ETCHEVERRY ET AL., Protein Engineering: Principles and Practice, WILEY-LISS, INC., (1996), vol. 163
DESCRIPTION- "Expression of foreign proteins in E. coli using plasmid vectors and purification of specific polyclonal antibodies", WILLIAMS ET AL., DNA Cloning 2: Expression Systems, OXFORD UNIVERSITY PRESS, (1995), vol. 15
DESCRIPTION- FAUCHERE, J. ADV. DRUG RES., (1986), vol. 15, page 29
DESCRIPTION- FEFER ET AL., CANCER J. SCI. AM., (1997), vol. 1, pages 548 - 53
DESCRIPTION- FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, (1991), vol. 2, page 95
DESCRIPTION- FRANCIS ET AL., INT J HEMATOL, (1998), vol. 68, page 1
DESCRIPTION- FUKUNAGA ET AL., J. BIOL. CHEM., (1995), vol. 270, page 25291
DESCRIPTION- FURKA, INT. J. PEPT. PROT. RES., (1991), vol. 37, pages 487 - 93
DESCRIPTION- FYFE ET AL., 7: CLIN. ONCOL., (1995), vol. 13, pages 688 - 96
DESCRIPTION- GAILLARDIN ET AL., CURR. GENET., (1985), vol. 10, page 49
DESCRIPTION- GARNICR ET AL., J. MOL. BIOI., (1978), vol. 120, page 97
DESCRIPTION- "Genetic Manipulation and Expression of Antibodies", WARD ET AL., Monoclonal Antibodies: Principles and Applications, WILEY-LISS, INC., (1995), vol. 137
DESCRIPTION- "Genetic Manipulation of Monoclonal Antibodies", COURTENAY-LUCK ET AL., Monoclonal Antibodies: Production, Engineering and Clinical Application, CAMBRIDGE UNIVERSITY PRESS, (1995), vol. 166
DESCRIPTION- GETIE; WARD, IMMUNOLOGY TODAY, (1997), vol. 18, page 592
DESCRIPTION- GLEESON ET AL., J. GEN. MICROBIOL., (1986), vol. 132, page 3459
DESCRIPTION- GOEDDEL ET AL., NATURE, (1979), vol. 281, page 544
DESCRIPTION- GOEDDEL ET AL., NUCLEIC ACIDS RES., (1980), vol. 8, page 4057
DESCRIPTION- GOMBOTZ; PETTIT, BIOCONJUGATE CHEM., (1995), vol. 6, page 332
DESCRIPTION- GORMAN ET AL., PROC. NATL. ACAD. SCI. USA, (1982), vol. 79, page 6777
DESCRIPTION- GRANTHAM ET AL., NUCL. ACIDS RES., (1980), vol. 8, page 1893
DESCRIPTION- GREEN ET AL., NATURE GENET., (1994), vol. 7, page 13
DESCRIPTION- GROSJEAN; FIERS, GENE, (1982), vol. 18, page 199
DESCRIPTION- GRUSSCNMCYCR ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, page 7952
DESCRIPTION- HAAS ET AL., CURR. BIOL., (1996), vol. 6, page 315
DESCRIPTION- HACKENG ET AL., PROC. NAT'L ACAD. SCI. USA, (1997), vol. 94, page 7845
DESCRIPTION- HAGIHARA ET AL., 1. AMER. CHEM. SOC., (1992), vol. 114, page 6568
DESCRIPTION- HAM; WALLACE, METH. ENZ., (1979), vol. 58, page 44
DESCRIPTION- HARASYM ET AL., ADV. DRUG DELIV. REV., (1998), vol. 32, page 99
DESCRIPTION- HENIKOFF; HENIKOFF, PROC. NATL. ACAD SCI. USA, (1992), vol. 89, page 10915
DESCRIPTION- HENIKOFF; HENIKOFF, PRUC. NAT7 ACAD. SCI. USA, (1992), vol. 89, page 10915
DESCRIPTION- HERBERMAN; ORTALDO, SCIENCE, (1981), vol. 214, pages 24 - 30
DESCRIPTION- HILTON ET AL., J. BIOL. C'HEM., (1996), vol. 271, page 4699
DESCRIPTION- HINNEN ET AL., PROC. NATL. ACAD. SCI. USA, (1978), vol. 75, page 1929
DESCRIPTION- HIRAKI ET AL., LUNG CANCER, (2002), vol. 35, pages 329 - 33
DESCRIPTION- HIRSCHMANN ET AL., J. AMER. CHEM. SOC., (1992), vol. 114, pages 9217 - 18
DESCRIPTION- HOBBS ET AL., PROC. NAT. ACAD. SCI. USA, (1993), vol. 90, pages 6909 - 13
DESCRIPTION- HOLM, NUC. ACIDS RES., (1986), vol. 14, page 3075
DESCRIPTION- HOLOWACHUK ET AL., PCR METHODS APPL., (1995), vol. 4, page 299
DESCRIPTION- HOPP ET AL., BIOTECHNOLOGY, (1988), vol. 6, page 1204
DESCRIPTION- HOPP ET AL., BIOTECHNOLOGY, (1988), vol. 6, pages 1204 - 1210
DESCRIPTION- HOPP ET AL., PROC. NAT'L ACAD. SCI. USA, (1981), vol. 78, page 3824
DESCRIPTION- HORISBERGER; DI MARCO, PHARMAC. THER., (1995), vol. 66, page 507
DESCRIPTION- HOUGHTON ET AL., NATURE, (1991), vol. 354, pages 84 - 88
DESCRIPTION- HU ET AL., CLIN. CANCER RES., (2004), vol. 10, pages 7662 - 70
DESCRIPTION- IKEMURA, J. MOL. BIOL., (1982), vol. 158, page 573
DESCRIPTION- "Immunochemical Applications of Avidin-Biotin Technology", BAYER ET AL., Methods In Molecular Biology, THE HUMANA PRESS, INC., (1992), vol. 10, pages 149 - 162
DESCRIPTION- "Implants in Drug Delivery", RANADE, Drug Delivery Systems, CRC PRESS, (1995), pages 95 - 123
DESCRIPTION- INBAR ET AL., PROC. NAT'L ACAD. SCI. USA, (1972), vol. 69, page 2659
DESCRIPTION- "Information Superhighway and Computer Databases of Nucleic Acids and Proteins", Methods in Gene Biotechnology, CRC PRESS, INC., (1997), pages 123 - 151
DESCRIPTION- ITAKURA ET AL., ANNU. REV. BIOCHEM., (1984), vol. 53, page 323
DESCRIPTION- JAMESON; WOLF, CABIOS, (1988), vol. 4, page 181
DESCRIPTION- JOHNSON ET AL., ANTICANCER RES., (1995), vol. 15, pages 1387 - 93
DESCRIPTION- JONASCH; HALUSKA, ONCOLOGIST, (2001), vol. 6, pages 34 - 55
DESCRIPTION- JONES ET AL., NATURE, (1986), vol. 321, page 522
DESCRIPTION- KANE, CURR. OPIN. BIOTECHNOL., (1995), vol. 6, page 494
DESCRIPTION- KARPLUS; SCHULTZ, NATURWISSENSCHAFTEN, (1985), vol. 72, page 212
DESCRIPTION- KATO ET AL., BIOL. PHARM. BULL., (1993), vol. 16, page 960
DESCRIPTION- KATO; SUGIYAMA, CRIT. REV. THER. DRUG CARRIER SYST., (1997), vol. 14, page 287
DESCRIPTION- KEILHOLZ ET AL., LEUK. LYMPHOMA, (1999), vol. 35, pages 641 - 2
DESCRIPTION- KELLY; HYNES, EMBO J., (1985), vol. 4, pages 475 - 479
DESCRIPTION- KENNEDY ET AL., CLIN. CHIM. ACTA, (1976), vol. 70, page 1
DESCRIPTION- KIM, DRUGS, (1993), vol. 46, page 618
DESCRIPTION- KNOWN ET AL., METHODS IN ENZYMOLOGY, (1990), vol. 185, pages 527 - 537
DESCRIPTION- KOHLCR ET AL., NATURE, (1975), vol. 256, page 495
DESCRIPTION- KOIDE ET AL., BIOCHEM., (1994), vol. 33, page 7470
DESCRIPTION- KüHNEL ET AL., PROC. NAT'L. ACAD. SCI. USA, (2004), vol. 101, page 17027
DESCRIPTION- KUNZE ET AL., J. BASIC MICROBIOL., (1985), vol. 25, page 141
DESCRIPTION- KURIAKOSE ET AL., HEAD NECK, (2000), vol. 22, pages 57 - 63
DESCRIPTION- KURTZ ET AL., MOL. CELL. BIOL., (1986), vol. 6, page 142
DESCRIPTION- LANDSCHULZ ET AL., SCIENCE, (1989), vol. 243, pages 1681 - 1688
DESCRIPTION- LARRICK ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, (1991), vol. 2, page 106
DESCRIPTION- LAU ET AL., BIOORG-MED-CHEM., (1995), vol. 3, pages 1299 - 1304
DESCRIPTION- LAU ET AL., BIOORG-MED-CHEM., (1995), vol. 3, pages 1305 - 12
DESCRIPTION- LAWRIE; TUMIN, CUR. OPIN. GENET. DEVELOP., (1993), vol. 3, pages 102 - 109
DESCRIPTION- LCBACQ-VERHEYDEN ET AL., MOL. CELL. BIOL., (1988), vol. 8, page 3129
DESCRIPTION- LEMAIGRE; ROUSSEAU, BIOCHEM. J., (1994), vol. 303, page 1
DESCRIPTION- LIANG ET AL., CURR. OPIN. IMMUNOL., (2002), vol. 14, pages 384 - 90
DESCRIPTION- LIANG ET AL., SCIENCE, (1996), vol. 274, pages 1520 - 22
DESCRIPTION- LI ET AL., ARCH. OTOLARYNGOL. HEAD NECK SURG., (2001), vol. 127, pages 1319 - 24
DESCRIPTION- LI ET AL., INT. J. GYNECOL. CANCER, (2005), vol. 15, pages 301 - 7
DESCRIPTION- LJUNGGRCN; MALMBCRG, NATURE REV. IMMUNOL., (2007), vol. 7, pages 329 - 339
DESCRIPTION- LJUNGGREN; KARRE, IMMUNOL. TODAY, (1990), vol. 11, pages 237 - 244
DESCRIPTION- LOEKEN, GENE EXPR., (1993), vol. 3, page 253
DESCRIPTION- LONBERG ET AL., NATURE, (1994), vol. 368, page 856
DESCRIPTION- LOSMAN ET AL., INT. J. CANCER, (1990), vol. 46, page 310
DESCRIPTION- LOWMAN ET AL., BIOCHEM., (1991), vol. 30, page 10832
DESCRIPTION- LUCKOW ET AL., BIO/1ECHNOLOGY, (1988), vol. 6, pages 47 - 55
DESCRIPTION- "Lymphoid neoplasms", American .1oínt Committee on Cancer.: AJCC Cancer Staging Manual, SPRINGER, (2002), pages 393 - 406
DESCRIPTION- MACDA ET AL., NATURE, (1985), vol. 315, pages 592 - 594
DESCRIPTION- MAEDA ET AL., NATURE, (1985), vol. 15, pages 592 - 594
DESCRIPTION- MAKRIDES, MICROBIOL. REV., (1996), vol. 60, page 512
DESCRIPTION- MARTIN ET AL., DNA, (1988), vol. 7, page 99
DESCRIPTION- MCGEHEE ET AL., MOL. ENDOCRINOL., (1993), vol. 7, page 551
DESCRIPTION- MEISEL ET AL., PLANT MOLEC. BIOL., (1996), vol. 30, page 1
DESCRIPTION- MERRIFIELD, J. AM. CHEM. SOC., (1963), vol. 85, page 2149
DESCRIPTION- Meth. Enzymol., (1990), vol. 182, page 529
DESCRIPTION- MILLER ET AL., ANN. REV. MICROHIOL., (1988), vol. 42, page 177
DESCRIPTION- MILLER ET AL., GENERIC ENGINEERING, (1986), vol. 8, pages 277 - 279
DESCRIPTION- MIYAJIMA ET AL., GENE, (1987), vol. 58, page 273
DESCRIPTION- MIYAKAWA ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (2004), vol. 313, pages 258 - 62
DESCRIPTION- MONKARSH ET AL., ANAL. BIOCHEM., (1997), vol. 247, page 434
DESCRIPTION- "Monoclonal Antibodies in Diagnostic Immunoassays", COOK; SELF, Monoclonal Antibodies: Production, Engineering, and Clinical Application, CAMBRIDGC UNIVERSITY PRESS, (1995), pages 180 - 208
DESCRIPTION- MORETTA ET AL., ANNU. REV. IMMUNOL., (2001), vol. 19, pages 197 - 223
DESCRIPTION- MOSMANN, J. IMMUNOL. METHODS, (1983), vol. 65, pages 55 - 63
DESCRIPTION- MUIR ET AL., PROC. NAT'L ACAD. SCI. USA, (1998), vol. 95, page 6705
DESCRIPTION- MURAHASHI ET AL., BIOL. PHARM. BULL., (1997), vol. 20, page 259
DESCRIPTION- MURPHY ET AL., EUR. J. IMMUNOL., (1990), vol. 20, pages 1729 - 1734
DESCRIPTION- MURPHY ET AL., IMMUNOL. REV., (2001), vol. 181, pages 279 - 289
DESCRIPTION- MURPHY ET AL., J. EXP. MED., (1987), vol. 165, pages 1212 - 1217
DESCRIPTION- MURPHY ET AL., J EXP. MED., (1987), vol. 166, pages 1499 - 1509
DESCRIPTION- MURPHY ET AL., J. IMMUNOL., (1990), vol. 144, pages 3305 - 3311
DESCRIPTION- MURPHY ET AL., J. NATL. CANCER INST., (1993), vol. 85, pages 1475 - 1482
DESCRIPTION- NEEDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, page 444
DESCRIPTION- NEMATI ET AL., CLIN CANCER RES., (2000), vol. 6, pages 2075 - 86
DESCRIPTION- NER ET AL., DNA, (1988), vol. 7, page 127
DESCRIPTION- NEVILLE ET AL., BIOL. CHEM., (1989), vol. 264, pages 14653 - 14661
DESCRIPTION- NIEFORTH ET AL., CLIN. PHARMACOL. THER., (1996), vol. 59, page 636
DESCRIPTION- NILSSON ET AL., EMBO J., (1985), vol. 4, page 1075
DESCRIPTION- NILSSON ET AL., METHODS ENZYMOL., (1991), vol. 198, page 3
DESCRIPTION- NISHISAKA ET AL., CYTOKINES CELL MOL THER., (2000), vol. 6, pages 199 - 206
DESCRIPTION- NISONOFF ET AL., ARCH BIOCHEM. BIOPHYS., (1960), vol. 89, page 230
DESCRIPTION- OHE ET AL., HUMAN GENE THERAPY, (1995), vol. 6, pages 325 - 333
DESCRIPTION- OHLCN ET AL., J. IMMUNOL., (1990), vol. 145, pages 52 - 58
DESCRIPTION- O'REILLY ET AL., J. BIOL. CHEM., (1992), vol. 267, page 19938
DESCRIPTION- O'REILLY ET AL., VOX. SANG., (1986), vol. 51, pages 81 - 86
DESCRIPTION- ORLANDI ET AL., PROC. NAT'L ACAD. SCI. USA, (1989), vol. 86, page 3833
DESCRIPTION- ORTALDO; HERBERMAN, ANNU. REV. INIMUNOL., (1984), vol. 2, pages 359 - 394
DESCRIPTION- OSTRO ET AL., AMERICAN J. HOSP. PHARM., (1989), vol. 46, page 1576
DESCRIPTION- OTTENSMEIER, CHEMICO-BIOLOGICAL INTERACTIONS, (2001), vol. 135-136, pages 653 - 664
DESCRIPTION- PACK ET AL., BIOLTECHNOLOGY, (1993), vol. 1 1, page 1271
DESCRIPTION- PADLAN, MOL. IMMUNOL., (1994), vol. 31, pages 169 - 217
DESCRIPTION- PAGE ET AL., INTI. J. OF ONCOLOGY, (1993), vol. 3, pages 473 - 476
DESCRIPTION- PEARSON; LIPMAN, PROC. NAT'I ACAD. SCI. USA, (1988), vol. 85, page 2444
DESCRIPTION- PEARSON, METH. ENZYMOL., (1990), vol. 183, page 63
DESCRIPTION- PENDE, I.EXP. MED., (1999), vol. 190, pages 1505 - 1516
DESCRIPTION- PETKOVA ET AL., INT. IMMUNOL., (2006), vol. 18, page 1759
DESCRIPTION- PIAZZA ET AL., CANCER RESEARCH, (1995), vol. 55, pages 3110 - 16
DESCRIPTION- PORRATA ET AL., BONE MARROW TRAMPLANT., (2001), vol. 28, pages 673 - 80
DESCRIPTION- PORTER, BIOCHEM. J., (1959), vol. 73, page 119
DESCRIPTION- "Prediction of Protein Structural Classes from Amino Acid Composition", CHOU, Prediction uf Protein Structure and the Principles of Protein Conformation, PLENUM PRESS, (1990), pages 549 - 586
DESCRIPTION- "Preparation and Use of Liposomes in Immunological Studies", ALVING ET AL., Liposome Technology, CRC PRESS, (1993), vol. III, page 317
DESCRIPTION- "Production of monoclonal antibodies against proteins expressed in E. coli", PICKSLEY ET AL., DNA Cloning 2: Expression Systems, OXFORD UNIVERSITY PRESS, (1995), vol. 93
DESCRIPTION- "Production of Polyclonal Antisera", GREEN ET AL., Immunochemical Protocols, HUMANA PRESS, (1992), vol. 1-5
DESCRIPTION- "Production of Polyclonal Antisera", GREEN ET AL., Methods In Molecular Biology: Immunochemical Protocols, HUMANA PRESS, (1992), pages 1 - 12
DESCRIPTION- "Protein Delivery with Infusion Pumps", BREMER ET AL., Protein Delivery: Physical Systems, PLENUM PRESS, (1997), pages 239 - 254
DESCRIPTION- "Purification of Immunoglobulin G (IgG)", BAINES ET AL., Methods in Molecular Biology, THE HUMANA PRESS, INC., (1992), vol. 10, pages 79 - 104
DESCRIPTION- "Purification of over-produced proteins from E. coli cells", GRISSHAMMER ET AL., DNA Cloning 2: Expression Systems, OXFORD UNIVERSITY PRESS, (1995), pages 59 - 92
DESCRIPTION- PUTNAM, The Plasma Proteins, ACADEMIC PRESS, INC., (1987), vol. V, pages 49 - 140
DESCRIPTION- PUTNCY; BURKE, NATURE BIOTECHNOLOGY, (1998), vol. 16, page 153
DESCRIPTION- PUTNEY, CURR. OPIN. CHEM. BIOL., (1998), vol. 2, page 548
DESCRIPTION- QUIDVILLE ET AL., ENDOCRINOLOGY, (2004), vol. 145, pages 2561 - 71
DESCRIPTION- REIDHAAR-OLSON; SAUER, SCIENCE, (1988), vol. 241, page 53
DESCRIPTION- REN, LEUKEMIA AND LYMPHOMA, (2002), vol. 8, pages 1549 - 1561
DESCRIPTION- ROBERTSON ET AL., J. AM. CHEM. SOC., (1991), vol. 113, page 2722
DESCRIPTION- ROGGENKAMP ET AL., MOL. GEN. GENET., (1986), vol. 202, page 302
DESCRIPTION- "Role of Polymers in Drug Delivery", RANADE, Drug Delivery Systems, CRC PRESS, (1995), pages 51 - 93
DESCRIPTION- ROSENBERG ET AL., CANCER RESEARCH, (1991), vol. 51, pages 5074 - 5079
DESCRIPTION- SACCHI ET AL., HAEMATOLOGICA, (2001), vol. 86, pages 951 - 8
DESCRIPTION- SANDHU, CRIT. REV. BIOTECH., (1992), vol. 12, page 437
DESCRIPTION- SCATCHARD, ANN. NY ACAD. SCI., (1949), vol. 51, page 660
DESCRIPTION- SCHERPHOF ET AL., ANN. N.Y. ACAD. SCI., (1985), vol. 446, page 368
DESCRIPTION- SCHURS ET AL., CLIN. CHIM. ACTA, (1977), vol. 81, page 1
DESCRIPTION- SCOTT ET AL., BLOOD, (1998), vol. 92, pages 4864 - 4871
DESCRIPTION- SELLERS, SIAM.I. APPL. MATH., (1974), vol. 26, page 787
DESCRIPTION- SEVERINOV; MUIR, J. BIOL. CHEM., (1998), vol. 273, page 16205
DESCRIPTION- SHARP; MATASSI, CURR. OPIN. GENET. DEV., (1994), vol. 4, page 851
DESCRIPTION- SHIH ET AL., INT'L J. CANCER, (1990), vol. 46, page 1101
DESCRIPTION- SHIMIZU ET AL., BIOL. PHARM. BULL., (1997), vol. 20, page 881
DESCRIPTION- SHRESTA ET AL., VIROLOGY, (2004), vol. 319, pages 262 - 273
DESCRIPTION- SIEBENLIST ET AL., CELL, (1980), vol. 20, page 269
DESCRIPTION- SINGER ET AL., J. IMMUN., (1993), vol. 150, page 2844
DESCRIPTION- "Sitc-Spccific Drug Delivery Using Liposomcs as Carricrs", RANADC, Drug Delivery Systems, CRC PRESS, (1995), pages 3 - 24
DESCRIPTION- "Site-Directed Mutagenesis and Protein Engineering", COOMBS; COREY, Proteins: Analysis and Design, ACADEMIC PRESS, INC., (1998), pages 259 - 311
DESCRIPTION- SKEHAN ET AL., J. NAT'L CANCER TNST., (1990), vol. 82, pages 1107 - 12
DESCRIPTION- SLAVIN; NAGLER, CANCER J. SCI. AM., (1997), vol. 1, pages 59 - 67
DESCRIPTION- SMITH, AIDS, (2001), vol. 15, no. 2, pages 28 - 35
DESCRIPTION- SMITH ET AL., J. MOL. BIOL., (1992), vol. 224, page 899
DESCRIPTION- SMITH ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, page 8844
DESCRIPTION- SMITH; JOHNSON, GENE, (1988), vol. 67, page 31
DESCRIPTION- SMYTH ET AL., NEJM, (2006), vol. 354, page 2282
DESCRIPTION- "Solid-Phase Peptide Synthesis", FIELDS; COLOWICK, Methods in Enzymology, ACADEMIC PRESS, (1997), vol. 289
DESCRIPTION- SRIVASTAVA, NEOPLASIA, (2001), vol. 3, pages 535 - 46
DESCRIPTION- SRIVASTAVA; SRIVASTAVA, LEUK. RES., (2006), vol. 30, pages 37 - 46
DESCRIPTION- STEIN ET AL., CANCER RES., (1990), vol. 50, page 1330
DESCRIPTION- STEMMER, NATURE, (1994), vol. 370, page 389
DESCRIPTION- STEMMER, PROC. NAT'L ACAD. SCI. USA, (1994), vol. 91, page 10747
DESCRIPTION- STORKUS ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 2361 - 2364
DESCRIPTION- SULKOWSKI, TRENDS IN BIOCHEM., (1985), vol. 3, page 1
DESCRIPTION- TAKEDA ET AL., J. EXP. MED., (2002), vol. 195, pages 161 - 9
DESCRIPTION- TAYLOR ET AL., INT. IMMUN., (1994), vol. 6, page 579
DESCRIPTION- "The EGF Receptor", HERSCHMAN ET AL., Control of Animal Cell Proliferation, ACADEMIC PRESS, (1985), vol. 1, pages 169 - 199
DESCRIPTION- "The Non-Hodgkin's Lymphoma Pathologic Classification Project", CANCER, (1982), vol. 49, pages 2112 - 35
DESCRIPTION- "The Role of Monoclonal Antibodies in the Advancement of Immunoassay Technology", PERRY, Monoclonal Antibodies: Principles and Applications, WILEY-LISS, INC., (1995), pages 107 - 120
DESCRIPTION- THORPE ET AL., CANCER RES., (1987), vol. 47, pages 5924 - 5931
DESCRIPTION- THORPE ET AL., IMMUNOL. REV., (1982), vol. 62, pages 119 - 58
DESCRIPTION- TILBURN ET AL., GENE, (1983), vol. 26, pages 205 - 221
DESCRIPTION- TREISMAN, SEMINARS IN CANCER BIOL., (1990), vol. 1, page 47
DESCRIPTION- TREUTER ET AL., MOLEC. GEN. GENET., (1993), vol. 240, page 113
DESCRIPTION- TRINCHIERI, ADV. IMMUNNL., (1989), vol. 47, pages 187 - 376
DESCRIPTION- TUAN ET AL., CONNECTIVE TISSUE RESEARCH, (1996), vol. 34, page 1
DESCRIPTION- TURCATTI ET AL., J. BIOL. CHEM., (1996), vol. 271, page 19991
DESCRIPTION- "Use of Degenerate Oligonucleotide Primers and the Polymerase Chain Reaction to Clone Gene Family Members", PRESTON, Methods in Molecular Biology, Vol. 1.5: PCR Protocols: Current Methods and Applications, HUMANA PRESS, INC., (1993), vol. 15
DESCRIPTION- "Use of the Polymerase Chain Reaction for the Rapid Construction of Synthetic Genes", DILLON ET AL., Methods in Molecular Biology, Vol. 15: PCR Protocols: Current Methods and Applications, HUMANA PRESS, INC., (1993), vol. 15, pages 263 - 268
DESCRIPTION- "Use of the Polymerase Chain Reaction to Screen Phage Libraries", YU ET AL., Methods in Molecular Biology, Vol. 15: PCR Protocols: Current Methods and Applications, HUMANA PRESS, INC., (1993), vol. 15
DESCRIPTION- VAN DEN BERG ET AL., BIOLTECHNOLOGY, (1990), vol. 8, page 135
DESCRIPTION- VAN ETTEN, BLOOD CELLS MOL. DIS., (2001), vol. 27, pages 201 - 205
DESCRIPTION- VAN THIEL ET AL., DIG. DIS. SCI., (1994), vol. 39, pages 970 - 976
DESCRIPTION- VARTHAKAVI; MINOCHA, J. GEN. VIROL., (1996), vol. 77, page 1875
DESCRIPTION- VAUGHN ET AL., NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 309 - 14
DESCRIPTION- VEBER; FREIDINGER, TINS, (1985), page 392
DESCRIPTION- VLAK ET AL., J. GEN. VIROL., (1988), vol. 69, pages 765 - 776
DESCRIPTION- WAIN-HOBSON ET AL., GENE, (1981), vol. 13, page 355
DESCRIPTION- WASSEF ET AL., METH. ENZYMOL., (1987), vol. 149, page 124
DESCRIPTION- WETMUR, CRIT. REV. BIOCHEM. MOL. BIOL., (1990), vol. 26, page 227
DESCRIPTION- WHITLOW ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, (1991), vol. 2, page 97
DESCRIPTION- WILCOX ET AL., J. CLIN. INVEST., (2002), vol. 109, pages 651 - 9
DESCRIPTION- WINES ET AL., I IMMUNNL., (2000), vol. 164, page 5313
DESCRIPTION- WLODAVER ET AL., FEBSLETT., (1992), vol. 309, page 59
DESCRIPTION- WONG; PALMER, ANNU. REV. IMMUNOL., (2003), vol. 21, pages 29 - 70
DESCRIPTION- WONG; WITTE, ONCOGENE, (2001), vol. 20, pages 5644 - 5659
DESCRIPTION- WOOF; BURTON, NATURE REVIEWS, (2004), vol. 4, page 1
DESCRIPTION- WOZNIAKOWSKA-GESICKA ET AL., POL. MERKURIUSZ LEK, (2000), vol. 8, pages 376 - 377
DESCRIPTION- WYNN; RICHARDS, PROTEIN SCI., (1993), vol. 2, page 395
DESCRIPTION- XIAO; BRANDSMA, NUCLEIC ACIDS. RES., (1996), vol. 24, pages 2630 - 2622
DESCRIPTION- YAMAGUCHI ET AL., BIOCHEM. PHARMACOL., (1995), vol. 50, page 1295
DESCRIPTION- YAMAZAKI ET AL., ONCOLOGY REPORTS, (2002), vol. 9, pages 359 - 363
DESCRIPTION- YE ET AL., J. BIOL. CHEM., (1994), vol. 269, page 25728
DESCRIPTION- YELTON ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 1470 - 1474
DESCRIPTION- YOUNES ET AL., CELL IMMUNOL., (1995), vol. 165, pages 243 - 51
DESCRIPTION- ZAKI ET AL., J. INVEST. DERMATOL., (2002), vol. 118, pages 366 - 71
DESCRIPTION- ZHOU ET AL., CLIN. CANCER RES., (2003), vol. 9, pages 6030 - 7
DESCRIPTION- ZHOU ET AL., J. EXP. MED., (1994), vol. 179, page 1867
EXAMINATION- NANCY KENDRICK, "A gene's mRNA level does not usually predict its protein level A gene's mRNA level does not usually predict its protein level", (20140925), URL: http://www.kendricklabs.com/WP1_mRNAvsProtein-New2014.pdf, (20151021), XP055222549
EXAMINATION- BRANDT CAMERON S ET AL, "The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 206, no. 7, doi:10.1084/JEM.20090681, ISSN 0022-1007, (20090706), pages 1495 - 1503, (20090615), XP009145615
INTERNATIONAL-SEARCH-REPORT- "Homo sapiens mRNA; cDNA DKFZp686I21167 (from clone DKFZp686I21167)", EMBL, (20040819), Database accession no. CR749521, URL: EBI, XP002628996 [X] 10-14 * the whole document * [A] 1-9,15-74
INTERNATIONAL-SEARCH-REPORT- MORETTA LORENZO ET AL, "Unravelling natural killer cell function: Triggering and inhibitory human NK receptors.", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, (20040128), vol. 23, no. 2, ISSN 0261-4189, pages 255 - 259, XP009145631 [A] 1-74 * the whole document *
INTERNATIONAL-SEARCH-REPORT- "RecName: Full=Putative Ig-like domain-containing protein DKFZp686O24166/DKFZp686I21167; Flags: Precursor;", UniProt, (20041011), Database accession no. Q68D85, URL: EBI, XP002628997 [A] 1-74 * the whole document *
INTERNATIONAL-SEARCH-REPORT- VON STRANDMANN ELKE POGGE ET AL, "Tumor cell-derived HLA-B-associated transkript 3 (BAT3) is a ligand for NKp30 and activates NK cells.", BLOOD, & 48TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ORLANDO, FL, USA; DECEMBER 09 -12, 2006, (200611), vol. 108, no. 11, Part 1, ISSN 0006-4971, page 194A, XP009145629 [A] 1-74 * the whole document *
INTERNATIONAL-SEARCH-REPORT- PENDE D ET AL, "Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, (19991115), vol. 190, no. 10, doi:DOI:10.1084/JEM.190.10.1505, ISSN 0022-1007, pages 1505 - 1516, XP002167575 [A] 1-74 * the whole document *
INTERNATIONAL-SEARCH-REPORT- BRANDT CAMERON S ET AL, "The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.", THE JOURNAL OF EXPERIMENTAL MEDICINE 6 JUL 2009 LNKD- PUBMED:19528259, (20090706), vol. 206, no. 7, ISSN 1540-9538, pages 1495 - 1503, XP009145615 [T] * the whole document *
OPPOSITION- "Chapter 3", Delves P. J. et al, Roitt's Essential Immunology. 11th Ed., Blackwell, (20060000), pages 37 - 59, XP055409002
OPPOSITION- JEFFERIS R., "Criteria for selection of IgG Isotype and glycoform of antibody therapeutics", BioProcess International, (20061000), pages 40 - 43, XP055206409
OPPOSITION- STROME S.E. et al., "A Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects", The Oncologist, (20070900), vol. 12, no. 9, pages 1084 - 1095, XP055052443
OPPOSITION- SCHNEIDER-MERCK T et al., "Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage", J. Immunol., (20100100), vol. 184, no. 1, pages 512 - 520, XP055270382

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents